Method for localized administration of fibrinolytic metalloproteinases

Details for Australian Patent Application No. 2006202029 (hide)

International Classifications

Event Publications

1 June 2006 Complete Application Filed

8 June 2006 Application Open to Public Inspection

Published as AU-A-2006202029

16 August 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

6 December 2007 Section 223 Application Received

Amgen Inc. An application to extend the time from 15 Dec 2006 to 15 Aug 2007 in which to pay a continuation fee has been filed . Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

31 January 2008 Section 223 Application Allowed

Amgen Inc. The time in which to pay a continuation fee has been extended to 15 Aug 2007. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

9 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.